Physician profile
Roberta Giudice-Teller
NPI 1710901145
$1,161.02
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $29.66 · 2022: $368 · 2023: $47.96 · 2024: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $216.13 | 2019-2024 | Novachor, Apligraf, Nushield |
| Horizon Therapeutics Plc | $138.33 | 2019-2020 | |
| Bioventus LLC | $133.30 | 2019-2022 | |
| Angiodynamics, INC. | $124.19 | 2022 | |
| Cook Medical LLC | $119.93 | 2022 | |
| Paragon 28, INC. | $94.04 | 2019 | |
| Aroa Biosurgery Incorporated | $94.02 | 2024 | |
| Grt US Holding, INC. | $89.83 | 2022 | |
| Smith+Nephew, INC. | $37.01 | 2019 | |
| Convatec INC. | $31.39 | 2023 | |
| Integra Lifesciences Corporation | $22.65 | 2019 | |
| Limflow INC. | $16.57 | 2023 | Limflow System |
| Paratek Pharmaceuticals, INC. | $15.70 | 2024 | Nuzyra |
| Misonix INC | $14.03 | 2019 | |
| Advanced Oxygen Therapy INC. | $13.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberta Giudice-Teller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.